Third Rock Ventures III, L.P. 3
Accession 0000899243-21-006212
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 8:32 AM ET
Size
16.3 KB
Accession
0000899243-21-006212
Insider Transaction Report
- 47,169
Common Stock
Series A Convertible Preferred Stock
→ Common Stock (2,938,945 underlying)Series C Convertible Preferred Stock
→ Common Stock (98,929 underlying)Series D Convertible Preferred Stock
→ Common Stock (54,642 underlying)
- 47,169
Common Stock
Series A Convertible Preferred Stock
→ Common Stock (2,938,945 underlying)Series C Convertible Preferred Stock
→ Common Stock (98,929 underlying)Series D Convertible Preferred Stock
→ Common Stock (54,642 underlying)
- 47,169
Common Stock
Series A Convertible Preferred Stock
→ Common Stock (2,938,945 underlying)Series C Convertible Preferred Stock
→ Common Stock (98,929 underlying)Series D Convertible Preferred Stock
→ Common Stock (54,642 underlying)
- 47,169
Common Stock
Series A Convertible Preferred Stock
→ Common Stock (2,938,945 underlying)Series C Convertible Preferred Stock
→ Common Stock (98,929 underlying)Series D Convertible Preferred Stock
→ Common Stock (54,642 underlying)
- 47,169
Common Stock
Series A Convertible Preferred Stock
→ Common Stock (2,938,945 underlying)Series C Convertible Preferred Stock
→ Common Stock (98,929 underlying)Series D Convertible Preferred Stock
→ Common Stock (54,642 underlying)
- 47,169
Common Stock
Series A Convertible Preferred Stock
→ Common Stock (2,938,945 underlying)Series C Convertible Preferred Stock
→ Common Stock (98,929 underlying)Series D Convertible Preferred Stock
→ Common Stock (54,642 underlying)
Footnotes (4)
- [F1]These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F2]The Series A Preferred Stock is convertible into common stock on a 15.529-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F3]The Series C Preferred Stock is convertible into common stock on a 12.6352-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date
- [F4]The Series D Preferred Stock is convertible into common stock on a 5.3-for-1 basis into the number of shares of common stock shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
Documents
Issuer
Decibel Therapeutics, Inc.
CIK 0001656536
Related Parties
1- filerCIK 0001569705
Filing Metadata
- Form type
- 3
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 8:32 AM ET
- Size
- 16.3 KB